Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > Safety Shot
View:
Post by Bigmac4000 on Dec 20, 2023 2:04am

Safety Shot

I was stuck in the Tokyo airport and was having beers with this guy that owns stock in Safety Shot. And we got talking about Celly vs Safety shot and I decided to buy some shares. Haven't had internet for a while but just looked and I paid $3.45 and today it's $4.59.  How's Celly doing? How long has FSD been under a buck? I made more in a week off Safety shot than FSD in 5 years. If it goes up another $1.00 it'll pay for this whole cruise.
Comment by lscfa on Dec 20, 2023 2:25am
Goldman Sachs forecasts Celly will do revenue of $42 million in 2024 and $138 million in 2025.   https://www.goldmanresearch.com/202311241387/Opportunity-Research/huge-pick-of-the-year.html
Comment by lscfa on Dec 20, 2023 2:36am
Singular research forecasts Celly revenues of $41 million in 2024 and $124 million in 2025 https://www.docdroid.net/kBAu1N9/fsd-pharma-inc-huge-analyst-research-report-by-singular-research-pdf#page=10
Comment by Bigmac4000 on Dec 21, 2023 10:25pm
Firstly, page 10 says it all. Significant losses and no source of revenue. Secondly how can anyone predict revenue or sales when there is no product. That's insanity at it's finest.  You can't assume sales of a product still in production with no proof of functionality.  Safety may or may not function as described but they sold out in days and the stock is doing very well ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities